The celiac disease clinic nurse’s communication challenge
Celiac disease presents the clinic nurse with a distinctive set of communication challenges that arise not from the complexity of the disease itself, but from the mismatch between how patients expect diseases to work and how this particular disease actually works. Most diseases signal their presence and activity through symptoms. Celiac disease does not reliably do this. A significant fraction of patients with biopsy-confirmed Marsh III villous atrophy on a normal gluten-containing diet have no meaningful gastrointestinal symptoms. Yet the immune process that produces that villous atrophy — the activation of gliadin-specific T cells, the intraepithelial lymphocyte attack on enterocytes, the inflammation in the lamina propria — carries real long-term risks that accumulate over years of untreated disease. The nurse who explains this must persuade a patient or family that a serious treatment (a permanent dietary restriction) is necessary for a disease that is not producing a serious experience.
The diagnostic pathway creates a second distinctive problem. The serologic test most commonly ordered for celiac disease — tTG-IgA — depends on the patient eating gluten at the time of testing. In the current environment, where gluten-free diets have cultural currency far beyond the celiac disease population, a substantial number of patients reach their first gastroenterology appointment already on a gluten-free diet, with negative antibody tests that their primary care physicians have interpreted as celiac disease excluded. Explaining why a negative test in this context means nothing — and why the patient may need to reintroduce a food that has been making them feel worse — requires navigating both the immunology of the antibody test and the patient’s reasonable reluctance.
The third challenge is the hidden failure modes of the gluten-free diet. A patient who has read the rules, is reading labels, is cooking at home, and is declining gluten-containing foods at every social occasion may still be consuming meaningful amounts of gluten through cross-contamination mechanisms that are not visible to a careful first-time patient. When symptoms persist on what the patient believes is a strict diet, the clinical conversation must translate general cross-contamination principles into the specific cookware, condiments, and ingredients that are most likely to be the culprit in this patient’s particular kitchen and food choices.
Three conversations that recur across the celiac disease clinic:
Scenario 1: Isabel Moreno-Castillo — 41, medical receptionist from Austin, Texas
Isabel Moreno-Castillo had never thought of herself as someone with a GI condition. She was the front-desk coordinator at a two-physician family medicine practice in Austin’s Round Rock suburb, and she was, by any ordinary measure, healthy. What brought her to her own physician’s attention was a hemoglobin of 9.8 g/dL and an MCV of 68 fL on routine annual labs — iron deficiency anemia, moderately severe. Isabel had attributed her fatigue to two young children and a forty-five-minute commute. Her physician ordered iron studies and found a ferritin of 4 ng/mL. She treated Isabel with oral iron for three months. The hemoglobin improved to 10.9 g/dL but did not normalize, and the ferritin remained at 6 ng/mL despite adequate compliance. Her physician recognized the pattern of iron deficiency anemia refractory to oral supplementation and referred Isabel to gastroenterology for evaluation of malabsorption.
The gastroenterology workup was systematic. Upper endoscopy found scalloping of the duodenal folds consistent with villous atrophy. Duodenal biopsies returned Marsh IIIb: marked villous atrophy, crypt hyperplasia, and intraepithelial lymphocytosis. tTG-IgA was 87 U/mL against a reference range of less than 4 U/mL. Anti-endomysial antibody was positive. Total IgA was normal, making IgA deficiency an unlikely cause of falsely low antibody titers. HLA genotyping confirmed DQ2 homozygosity. The diagnosis was celiac disease, serologically and histologically confirmed.
Isabel had no meaningful abdominal symptoms. She had occasional gas, but she had always had gas. No diarrhea. No abdominal pain. The gastroenterologist explained that her celiac disease was the reason her iron deficiency anemia had not responded to oral supplementation: the villous atrophy in her proximal duodenum was blunting the absorptive surface area where dietary iron was absorbed, and her intestine could not absorb the supplemental iron efficiently enough to normalize stores. He told her she needed a strict, lifelong gluten-free diet.
Isabel had gone home and told her mother, Carmen. Carmen was a retired schoolteacher from Laredo who had lived through a generation in which food was medicine and medicine was food, and who had strong opinions about both. She could not reconcile what Isabel had told her with any diagnosis she recognized.
“Pero Isabel, si no te duele el estómago,” Carmen said, “¿por qué te dicen que tienes una enfermedad intestinal seria? Y si la enfermedad es seria, ¿por qué el tratamiento es dejar el pan y la pasta en vez de tomar un medicamento?” (But Isabel, if your stomach doesn’t hurt, why are they saying you have a serious intestinal disease? And if the disease is serious, why is the treatment to stop eating bread and pasta instead of taking a medication?)
Isabel had brought both questions to her first appointment with the celiac disease clinic nurse, Adriana Fuentes-Reyes. “Mi mamá no entiende por qué tengo que seguir una dieta de por vida si no tengo síntomas en el estómago,” she said. “Y siendo honesta, yo tampoco estoy completamente segura. ¿Puede explicarme por qué la dieta es necesaria si no me siento mal cuando como gluten?” (My mother cannot understand why I have to follow a lifelong diet if I have no stomach symptoms. And honestly, I’m not completely sure either. Can you explain to me why the diet is necessary if I don’t feel bad when I eat gluten?)
Adriana had heard this question — in various forms and from various family members — at nearly every new celiac disease diagnosis appointment. She recognized it as the most important educational conversation in celiac disease care: the one that determined whether a patient would actually follow the diet. “Es una pregunta muy razonable,” she said, “y la respuesta requiere entender qué clase de enfermedad es la celiaquía — porque no funciona como la mayoría de las enfermedades que conocemos.” (It is a very reasonable question, and the answer requires understanding what kind of disease celiac disease is — because it does not work like most diseases we know.)
She began with the mechanism. In celiac disease, she explained, the problem was not in the stomach, the gallbladder, or the liver — it was in the immune system of the small intestine. People who carry certain genetic variants, called HLA-DQ2 or HLA-DQ8 (Isabel had DQ2 on both copies), have an immune system that misidentifies gliadin — the protein in wheat, rye, and barley that is collectively called gluten — as a threat. When gliadin crosses from the intestinal cavity into the wall of the small intestine, the immune system activates T cells that attack the intestinal lining. The attack is targeted at the villi: the tiny finger-like projections that cover the inside surface of the small intestine like a carpet and that are responsible for absorbing nutrients from digested food.
“Cuando las vellosidades están dañadas,” Adriana said, “el área de superficie del intestino para absorber hierro, calcio y vitaminas se reduce mucho — como si el tapete del intestino se hubiera desgastado a parches. Esa es la razón de la anemia de Isabel: el intestino no puede absorber bien el hierro del suplemento porque las vellosidades que harían esa absorción están atrofiadas. La biopsia de Isabel mostró un Marsh IIIb — eso significa atrofia marcada, no atrofia leve.” (When the villi are damaged, the surface area of the intestine for absorbing iron, calcium, and vitamins is greatly reduced — as if the intestinal carpet had worn away in patches. That is the reason for Isabel’s anemia: the intestine cannot absorb iron from the supplement well because the villi that would do that absorption are atrophied. Isabel’s biopsy showed Marsh IIIb — that means marked atrophy, not mild atrophy.)
Carmen leaned forward. “¿Y por qué no duele?” (And why doesn’t it hurt?)
“Eso es exactamente lo que hace especial a la celiaquía,” Adriana said. “El daño que produce el sistema inmune en las vellosidades intestinales no activa necesariamente las fibras del dolor de la misma manera que una úlcera o una colitis. Aproximadamente tres de cada diez personas con celiaquía confirmada por biopsia con atrofia marcada — Marsh III, igual que Isabel — no tienen síntomas gastrointestinales significativos. El sistema inmune está destruyendo vellosidades silenciosamente. El intestino no duele. El problema se manifiesta como anemia, como osteoporosis cuando los huesos pierden calcio durante años, o como infertilidad cuando la mala absorción de folato afecta el inicio del embarazo.” (That is exactly what makes celiac disease special. The damage the immune system produces in the intestinal villi does not necessarily activate the pain fibers in the same way as an ulcer or colitis. Approximately three out of ten people with celiac disease confirmed by biopsy with marked atrophy — Marsh III, same as Isabel — have no significant gastrointestinal symptoms. The immune system is silently destroying villi. The intestine does not hurt. The problem manifests as anemia, as osteoporosis when the bones lose calcium over years, or as infertility when folate malabsorption affects the start of pregnancy.)
She addressed the long-term risk directly. The persistent activation of T cells in the intestinal wall — the same T cells that destroyed Isabel’s villi every time gliadin arrived in her duodenum — had been shown in large population studies to carry a 3 to 7 times elevated risk of a specific type of intestinal lymphoma: enteropathy-associated T-cell lymphoma, or EATL. EATL was rare in absolute terms, but it was an aggressive lymphoma with poor prognosis compared to most other lymphoma types, and it arose specifically in people with untreated or refractory celiac disease. The magnitude of the risk was not trivial: some estimates placed the lifetime EATL risk in untreated celiac patients at approximately 0.3 to 1 percent, which was a small absolute probability but a 3 to 7 times elevation over the background rate in the general population.
“¿Y si sigo la dieta, ese riesgo desaparece?” Isabel asked. (And if I follow the diet, does that risk disappear?)
“La evidencia disponible indica que el riesgo del linfoma se reduce significativamente — y después de cinco años de dieta estricta sin gluten, el riesgo llega a niveles comparables a la población general,” Adriana said. “La dieta sin gluten es el único tratamiento para la celiaquía. No hay medicamento que bloquee la respuesta inmune al gluten de manera que sea segura para uso a largo plazo. La dieta detiene el estímulo que activa el sistema inmune — sin gluten llegando a la pared intestinal, los linfocitos T no tienen el disparador para atacar las vellosidades. Las vellosidades sanan. La absorción de hierro y calcio se normaliza. La anemia de Isabel debería resolverse en seis a doce meses de dieta estricta.” (The available evidence indicates that the lymphoma risk is significantly reduced — and after five years of strict gluten-free diet, the risk reaches levels comparable to the general population. The gluten-free diet is the only treatment for celiac disease. There is no medication that blocks the immune response to gluten in a way that is safe for long-term use. The diet stops the stimulus that activates the immune system — without gluten reaching the intestinal wall, the T lymphocytes have no trigger to attack the villi. The villi heal. Iron and calcium absorption normalizes. Isabel’s anemia should resolve in six to twelve months of strict diet.)
Carmen was quiet for a moment. “¿Entonces la dieta es el medicamento?” she asked. (So the diet is the medication?)
“Sí,” Adriana said. “En la celiaquía, la dieta es el medicamento. El gluten es el toxínico. Sin el tóxico, el intestino sana. Con el tóxico, el intestino se daña, aunque no duela.” (Yes. In celiac disease, the diet is the medication. Gluten is the toxin. Without the toxin, the intestine heals. With the toxin, the intestine is damaged, even if it does not hurt.)
Isabel left the appointment with a referral to a registered dietitian who specialized in celiac disease, a prescription for iron supplementation to be continued until her repeat iron studies normalized, a schedule for a repeat tTG-IgA and repeat duodenal biopsy at twelve months to confirm mucosal healing, and a DEXA scan order to assess bone mineral density after what appeared to have been years of calcium malabsorption. She also left with something she had not had when she arrived: a reason that made sense to her.
“Le voy a decir a mi mamá que la dieta es el medicamento,” she said to Adriana on the way out. “Creo que eso es lo que no habíamos entendido.” (I am going to tell my mother that the diet is the medication. I think that is what we had not understood.)
Scenario 2: Marco Vega-Ruiz — 28, construction project manager from Dallas, Texas
Marco Vega-Ruiz managed commercial construction projects for a mid-sized Dallas contractor, and he had the organized, methodical habits of someone accustomed to tracking dependencies and anticipating problems before they materialized. When his younger sister Lucia, 24, was diagnosed with celiac disease — tTG-IgA of 94 U/mL, Marsh IIIb biopsy, diagnosed after years of bloating and diarrhea — Marco had immediately researched the heritability. Celiac disease followed HLA-DQ2 and HLA-DQ8 genetics and was familial: first-degree relatives of celiac patients had a 4 to 15 percent probability of also having celiac disease, depending on the degree of shared genetic material and the HLA haplotypes involved. Marco had always had some digestive irregularity — nothing severe, but he had learned to avoid eating before long site visits. He decided to test himself.
The logical first step, in Marco’s view, was to eliminate gluten from his diet and observe whether his symptoms improved. He was systematic about it: he read about the gluten-free diet, identified the foods to avoid, switched to GF bread and pasta, and stopped eating wheat in any identifiable form. After three months, his digestive irregularity had somewhat improved — though he was not certain whether this was the diet or just better eating habits generally. He went to his primary care physician and explained that he wanted to test for celiac disease because his sister had been diagnosed.
His physician drew a tTG-IgA. The result came back 3 U/mL — below the reference range upper limit of 4 U/mL. Normal. Negative. His physician told him the celiac test was negative and that he did not appear to have celiac disease. Marco was satisfied with this conclusion and texted Lucia that he had tested negative.
Lucia called the celiac disease clinic nurse, Patricia Salinas-Moreno, in some alarm. She had read enough about celiac disease diagnosis to know that a tTG-IgA drawn after three months on a gluten-free diet was not a valid test. Patricia suggested that Marco come in for a consultation.
When Marco arrived, Patricia started with his timeline. He had been gluten-free for three months before the antibody test. “¿Cuándo fue el último día que comió gluten antes de hacerse la prueba?” she asked. (When was the last day you ate gluten before the test was done?)
“Aproximadamente tres meses antes — dejé el gluten tres meses antes de la cita con el médico,” Marco said. (Approximately three months before — I eliminated gluten three months before the appointment with the doctor.)
“Entiendo. Entonces la prueba que le hicieron no tiene valor diagnóstico para la celiaquía,” Patricia said. “Y quiero explicarle exactamente por qué, porque necesita entender el mecanismo para decidir cómo proceder.” (I understand. So the test they did has no diagnostic value for celiac disease. And I want to explain exactly why, because you need to understand the mechanism to decide how to proceed.)
She explained what the tTG-IgA actually measured. The test detected IgA antibodies directed against tissue transglutaminase 2 — an enzyme in the intestinal wall that modified gliadin peptides in a way that made the immune system react more strongly to them. These antibodies were produced by the intestinal immune system in response to the inflammation that gliadin was causing in the mucosa. When gliadin arrived in the small intestine in a person with celiac disease, it activated an immune response: CD4+ T cells recognized the gliadin peptides, inflammatory cytokines were released, intraepithelial lymphocytes attacked enterocytes, and as part of that immune response, B cells in the intestinal mucosa produced tTG-IgA antibodies. The tTG-IgA level in the blood was a measure of how actively this mucosal immune response was occurring at the time the blood was drawn.
“Cuando usted dejó de comer gluten,” Patricia said, “el gluten dejó de llegar a la pared del intestino. La respuesta inmune en la mucosa intestinal se calmó. Las células B que producían los anticuerpos tTG-IgA dejaron de recibir el estímulo que las activaba. Los anticuerpos que ya estaban en circulación fueron eliminados gradualmente por el organismo, como ocurre con todos los anticuerpos IgA. En personas con celiaquía confirmada que empiezan una dieta sin gluten estricta, los niveles de tTG-IgA vuelven a la normalidad en seis a doce meses. En alguien que llevaba solo tres meses sin gluten, los niveles ya podían ser normales.” (When you stopped eating gluten, gluten stopped arriving at the intestinal wall. The mucosal immune response calmed down. The B cells that were producing tTG-IgA antibodies stopped receiving the stimulus that was activating them. The antibodies already in circulation were gradually eliminated by the body, as happens with all IgA antibodies. In people with confirmed celiac disease who start a strict gluten-free diet, tTG-IgA levels return to normal in six to twelve months. In someone who had been gluten-free for only three months, levels could already be normal.)
Marco processed this carefully. “Entonces la prueba negativa no me dice si tengo celiaquía o no — solo me dice que no estaba comiendo gluten cuando me hicieron la prueba,” he said. (So the negative test does not tell me whether I have celiac disease or not — it only tells me I was not eating gluten when the test was done.)
“Exactamente eso,” Patricia said. “Una prueba de tTG-IgA en alguien que ya dejó el gluten es como medir la fiebre después de que el paciente tomó acetaminofén — si sale normal, no sabemos si había fiebre o no porque la medicación podría haberla bajado. En el caso de la celiaquía, el ‘acetaminofén’ es el gluten que falta.” (Exactly that. A tTG-IgA test in someone who has already eliminated gluten is like measuring fever after the patient took acetaminophen — if it is normal, we do not know whether there was fever or not because the medication could have lowered it. In the case of celiac disease, the ‘acetaminophen’ is the missing gluten.)
She laid out his two options. The first was a deliberate gluten challenge: reintroduce gluten at a minimum of 3 grams per day — roughly the equivalent of two slices of regular bread, or a portion of regular pasta — for 6 to 8 weeks, and then repeat the tTG-IgA and, if elevated, proceed to upper endoscopy with duodenal biopsy. Six to eight weeks, she explained, was the minimum needed to reliably re-elevate tTG-IgA in patients with celiac disease who had been gluten-free; some guidelines recommended up to 12 weeks for biopsy to be reliably positive. This would give a definitive answer but would require Marco to eat gluten for weeks, which might reproduce the digestive symptoms he had been relieved to be free of.
“¿Y si no quiero volver a comer gluten porque me siento mejor sin él?” Marco asked. (And if I do not want to return to eating gluten because I feel better without it?)
“En ese caso hay una segunda opción: la prueba genética del HLA,” Patricia said. “Casi el 99 por ciento de las personas con celiaquía tienen los genes HLA-DQ2 o HLA-DQ8. Y esos genes no cambian con la dieta — son parte de su ADN. Si los genes HLA-DQ2 y HLA-DQ8 son negativos, la probabilidad de tener celiaquía es menor de 1 en 100. Podemos excluir prácticamente el diagnóstico sin que usted tenga que volver a comer gluten. La prueba genética no confirma celiaquía — solo la excluye si es negativa. Si da positivo para DQ2 o DQ8, habría que hacer el reto con gluten para confirmar.” (In that case there is a second option: the HLA genetic test. Nearly 99 percent of people with celiac disease carry the HLA-DQ2 or HLA-DQ8 genes. And those genes do not change with diet — they are part of your DNA. If both HLA-DQ2 and HLA-DQ8 are negative, the probability of having celiac disease is less than 1 in 100. We can practically exclude the diagnosis without you having to return to eating gluten. The genetic test does not confirm celiac disease — it only excludes it if negative. If positive for DQ2 or DQ8, a gluten challenge would be needed to confirm.)
Marco thought for a moment. “Hagamos la prueba genética primero,” he said. “Si es negativa, termina el asunto. Si es positiva, decido si hago el reto.” (Let’s do the genetic test first. If it is negative, the matter is over. If positive, I decide whether to do the challenge.)
His HLA genotyping returned HLA-DQ2.5 homozygous. The same haplotype as his sister. Patricia scheduled his gluten challenge and follow-up tTG-IgA at eight weeks. His tTG-IgA at week eight was 78 U/mL. His EGD showed scalloping of duodenal folds and Marsh IIIa on biopsy. The diagnosis was confirmed.
At the confirmation appointment, Marco was matter-of-fact. “Bien,” he said. “Ahora sé lo que tengo. Tengo cómo manejarlo.” (Good. Now I know what I have. I know how to manage it.) He had already asked his sister for her dietitian’s contact information.
Scenario 3: Daniela Espinoza-Torres — 35, bilingual school counselor from San Antonio, Texas
Daniela Espinoza-Torres had been the school counselor at a Title I elementary school in San Antonio’s Westside for six years, and she was good at her work in part because she was methodical about understanding problems before trying to solve them. When she was diagnosed with celiac disease three months ago — tTG-IgA of 112 U/mL, Marsh IIIc biopsy on presentation with bloating, fatigue, loose stools, and what she described as a persistent “foggy feeling” in the late afternoon — she had approached the gluten-free diet with the same systematic attention she brought to her work. She read a 300-page celiac disease reference book. She joined an online celiac disease community. She read every label. She cooked at home almost every day. She had declined a colleague’s birthday cake and the pan dulce at a school-wide celebration. She had even replaced her usual afternoon granola bar with a version specifically labeled certified gluten-free.
At twelve weeks, she was still symptomatic. Not as severely as before diagnosis, but the bloating, the loose stools, and the fog had not resolved in the way the gastroenterologist had described they would. She came to her scheduled follow-up with the celiac clinic nurse, Rosa Jiménez-Vargas, with a written list of everything she ate in a week. “He hecho todo lo que me dijeron,” she said. “Leo etiquetas, cocino en casa, no como nada con gluten. Y todavía tengo los síntomas. ¿Hay algo que esté haciendo mal sin darme cuenta?” (I have done everything they told me. I read labels, I cook at home, I eat nothing with gluten. And I still have symptoms. Is there something I am doing wrong without realizing it?)
Rosa recognized this as the most forensic kind of celiac disease appointment: the diet investigation. “Lo que describe — dieta correcta en el papel pero síntomas que persisten — es más frecuente de lo que parece, y en la mayoría de los casos hay una o dos fuentes específicas de gluten que son invisibles para una persona cuidadosa pero nueva en la dieta,” she said. “Vamos a revisar la lista juntas.” (What you describe — correct diet on paper but persistent symptoms — is more common than it seems, and in most cases there are one or two specific gluten sources that are invisible to a careful but new-to-the-diet person. Let’s review the list together.)
She started with kitchen equipment. “¿Usa un tostador separado para el pan sin gluten, o el mismo que usa toda la familia?” (Do you use a separate toaster for gluten-free bread, or the same one the whole family uses?)
Daniela paused. “El mismo. Pensé que si limpiaba las migas no había problema.” (The same. I thought if I cleaned the crumbs it would not be a problem.)
“Las tostadoras son difíciles de limpiar completamente,” Rosa said. “Las resistencias, las ranuras laterales y el fondo acumulan migas de pan regular que no se ven después de limpiar por fuera. El pan sin gluten que se pone en las mismas ranuras toca esas superficies contaminadas. Para las personas con celiaquía, la cantidad de gluten necesaria para activar la respuesta inmune y causar daño en la mucosa es muy pequeña — algunos estudios sugieren que 10 miligramos de gluten por día de forma crónica pueden mantener una inflamación activa. Una tostada en un tostador compartido puede transferir más que eso.” (Toasters are hard to clean completely. The heating elements, the side slots, and the bottom accumulate regular bread crumbs that are not visible after cleaning the outside. Gluten-free bread placed in the same slots touches those contaminated surfaces. For people with celiac disease, the amount of gluten needed to activate the immune response and cause mucosal damage is very small — some studies suggest that 10 milligrams of gluten per day chronically can maintain active inflammation. One piece of toast in a shared toaster can transfer more than that.)
She went down the list. “¿Tiene escurridor propio para la pasta sin gluten, o usa el mismo escurridor que la familia usa para la pasta regular?” (Do you have a separate colander for gluten-free pasta, or do you use the same colander the family uses for regular pasta?)
“El mismo,” Daniela said again. “Lo lavo bien antes de usarlo.” (The same. I wash it well before using it.)
“Los escurridores de plástico y los de metal con bordes texturizados son difíciles de limpiar completamente de residuo de gluten,” Rosa said. “Los poros y las ranuras retienen partículas de harina y almidón que resisten el lavado ordinario. Los escurridores de madera son peores todavía. Para celiaquía, se recomienda un escurridor dedicado — marcado para uso exclusivo de alimentos sin gluten, guardado separado.” (Plastic colanders and metal ones with textured edges are hard to clean completely of gluten residue. The pores and grooves retain flour and starch particles that resist ordinary washing. Wooden colanders are even worse. For celiac disease, a dedicated colander is recommended — marked for exclusive use with gluten-free foods, stored separately.)
She continued. The shared butter in the refrigerator — a single family tub that Daniela’s husband used to spread on regular toast and her children used to spread on regular bread. Every time a spreader dipped into the butter after touching wheat bread transferred crumbs into the container. Each subsequent use by Daniela carried those crumbs onto her gluten-free toast. The same problem applied to the family peanut butter jar. “¿Tiene sus propios envases de mantequilla y de mantequilla de cacahuate, marcados para uso exclusivo suyo?” Rosa asked. (Do you have your own containers of butter and peanut butter, marked for exclusive use by you?)
Daniela shook her head slowly. “No había pensado en eso.” (I had not thought about that.)
Rosa moved to ingredient labeling. “¿Usa salsa de soja en casa — para cocinar arroz o pollo?” (Do you use soy sauce at home — for cooking rice or chicken?)
“Sí, la Kikkoman normal,” Daniela said. (Yes, regular Kikkoman.)
“La Kikkoman regular — y la mayoría de las salsas de soja que se encuentran en el supermercado — están elaboradas con trigo,” Rosa said. “El trigo está en el proceso de fermentación. El reemplazo es el tamari, que es una salsa elaborada sin trigo y está ampliamente disponible. También hay que revisar el vinagre de malta — que viene de la cebada y aparece en muchas papas fritas y condimentos — y el extracto de malta en algunos cereales etiquetados sin gluten. El extracto de malta viene de la cebada y contiene gluten aunque el cereal diga ‘sin gluten’ en la caja por otra razón.” (Regular Kikkoman — and most soy sauces found in the supermarket — are made with wheat. Wheat is in the fermentation process. The replacement is tamari, which is a sauce made without wheat and is widely available. You also need to check malt vinegar — which comes from barley and appears in many flavored chips and condiments — and malt extract in some cereals labeled gluten-free. Malt extract comes from barley and contains gluten even if the cereal says ‘gluten-free’ on the box for another reason.)
Daniela had been noting everything on her phone. Then Rosa asked about the granola bars. “¿Cuál es la marca de la barra de granola que compra? ¿Tiene avena?” (What brand is the granola bar she buys? Does it have oats?)
“Sí, pero pone ‘avena certificada sin gluten’,” Daniela said. “Pensé que era segura.” (Yes, but it says ‘certified gluten-free oats.’ I thought it was safe.)
Rosa took a moment to explain the distinction that most patients who had done their research did not yet know. Certified gluten-free oats, she explained, meant that the oats had been grown, harvested, and processed in a way that prevented contamination with wheat, rye, or barley. The certification addressed the question of whether the oats had been contaminated with gluten from another grain. It did not address a different question: whether the oats themselves contained a protein that some people with celiac disease reacted to.
“La avena contiene una prolamina — una proteína de almacenamiento — que se llama avenina,” she said. “La avenina tiene una estructura similar a la gliadina del trigo. La mayoría de las personas con celiaquía — aproximadamente el 90 a 95 por ciento — toleran la avena certificada sin gluten sin reacción inmune intestinal. Pero un 5 a 10 por ciento de las personas con celiaquía montan una respuesta inmune a la avenina similar a la que montan al trigo. Esa respuesta inmune activa los mismos mecanismos — intraepiteliales, inflamatorios — que la gliadina del trigo. Y ocurre aunque la avena sea perfectamente libre de contaminación con trigo, porque el problema es la proteína de la avena en sí misma, no el trigo de contaminación.” (Oats contain a prolamin — a storage protein — called avenin. Avenin has a structure similar to wheat gliadin. The majority of people with celiac disease — approximately 90 to 95 percent — tolerate certified gluten-free oats without an intestinal immune reaction. But 5 to 10 percent of people with celiac disease mount an immune response to avenin similar to their response to wheat. That immune response activates the same mechanisms — intraepithelial, inflammatory — as wheat gliadin. And it occurs even if the oats are perfectly free of wheat contamination, because the problem is the oat protein itself, not the contaminating wheat.)
Daniela looked at Rosa carefully. “¿Y no hay manera de saber si soy de ese grupo antes de tener síntomas?” (And is there no way to know if I am in that group before having symptoms?)
“La forma más práctica es eliminar la avena por completo durante cuatro semanas — incluyendo la avena certificada sin gluten — y observar si los síntomas mejoran,” Rosa said. “Si mejoran significativamente al eliminar la avena, eso es evidencia suficiente de que la avenina está contribuyendo a los síntomas. Después, si quiere confirmar, se puede reintroducir la avena de forma controlada y ver si los síntomas vuelven.” (The most practical approach is to eliminate oats completely for four weeks — including certified gluten-free oats — and observe whether symptoms improve. If they improve significantly with oat elimination, that is sufficient evidence that avenin is contributing to the symptoms. Afterward, if you want to confirm, oats can be reintroduced in a controlled way and you can see if symptoms return.)
Between the toaster, the colander, the shared condiment jars, the soy sauce, and the oat granola bars, Daniela had identified five separate gluten sources that her systematic label-reading had not detected. She left with a concrete action list: a dedicated toaster, a dedicated colander, personal condiment containers, tamari replacing soy sauce, and a complete elimination of oats for four weeks.
By the four-week check-in, her symptoms were substantially improved. By week eight, the bloating and the afternoon fog were gone. At her twelve-month follow-up, her tTG-IgA was 4 U/mL — just at the upper boundary of normal, suggesting mild ongoing exposure from a small residual source, or possibly from the avenin before the oat elimination. Her repeat biopsy at twelve months showed Marsh I: significant improvement from Marsh IIIc at diagnosis, but not complete mucosal healing. Rosa scheduled a follow-up biopsy at twenty-four months and continued working through the diet with her.
“Pensé que estaba haciendo todo bien,” Daniela said at the twelve-month visit. “Y estaba haciendo casi todo bien. Casi no era suficiente.” (I thought I was doing everything right. And I was doing almost everything right. Almost was not enough.)
Eight practical phrases for celiac disease clinic nurses
- Explaining why no GI symptoms does not mean no intestinal damage: “La celiaquía es una enfermedad autoinmune — el sistema inmune ataca las vellosidades del intestino cuando llega gluten, con o sin síntomas. Aproximadamente 3 de cada 10 personas con celiaquía confirmada por biopsia con atrofia marcada no tienen dolor de estómago ni diarrea. El daño en el intestino ocurre en silencio. La dieta sin gluten cura las vellosidades y previene las complicaciones a largo plazo — osteoporosis, anemia crónica, y en casos raros un tipo de linfoma intestinal.” (Celiac disease is an autoimmune disease — the immune system attacks the intestinal villi when gluten arrives, with or without symptoms. Approximately 3 in 10 people with celiac disease confirmed by biopsy with marked atrophy have no stomach pain or diarrhea. The intestinal damage occurs silently. The gluten-free diet heals the villi and prevents long-term complications — osteoporosis, chronic anemia, and in rare cases a type of intestinal lymphoma.)
- Explaining why tTG-IgA testing requires active gluten consumption: “La prueba de anticuerpos tTG-IgA mide la reacción del sistema inmune del intestino al gluten en el momento de la prueba. Si ya dejó el gluten, el sistema inmune dejó de reaccionar y los anticuerpos vuelven a niveles normales en semanas. Una prueba negativa hecha con dieta sin gluten no excluye la celiaquía — para que la prueba funcione, hay que estar comiendo gluten durante al menos seis a ocho semanas antes del análisis.” (The tTG-IgA antibody test measures the intestinal immune system’s reaction to gluten at the moment of testing. If gluten was already eliminated, the immune system stopped reacting and antibodies return to normal levels in weeks. A negative test done while on a gluten-free diet does not exclude celiac disease — for the test to work, the patient must be eating gluten for at least six to eight weeks before testing.)
- Explaining the HLA-DQ2/DQ8 genetic test as an alternative when a patient cannot do a gluten challenge: “Si no quiere volver a comer gluten porque le produce muchos síntomas, hay otra opción: una prueba genética del HLA que no cambia con la dieta. Casi el 99 por ciento de las personas con celiaquía tienen los genes HLA-DQ2 o HLA-DQ8. Si esos genes son negativos, la probabilidad de tener celiaquía es menor del 1 por ciento — se puede descartar prácticamente. Si son positivos, eso no confirma celiaquía pero indica que hay riesgo y habría que hacer el reto con gluten en el momento en que esté dispuesto.” (If you do not want to return to eating gluten because it produces many symptoms, there is another option: an HLA genetic test that does not change with diet. Nearly 99 percent of people with celiac disease have the HLA-DQ2 or HLA-DQ8 genes. If those genes are negative, the probability of having celiac disease is less than 1 percent — it can practically be ruled out. If positive, that does not confirm celiac disease but indicates risk and a gluten challenge would be needed when you are willing.)
- Explaining the toaster and colander cross-contamination risk: “El tostador compartido con pan regular es una de las fuentes más comunes de contaminación con gluten que los pacientes no detectan. Las migas de pan se acumulan en las resistencias y el fondo y no se eliminan con la limpieza ordinaria. Para la celiaquía, se necesita un tostador dedicado solo para pan sin gluten — marcado y guardado separado. Lo mismo ocurre con el escurridor de pasta, las tablas de madera, y los cucharones de madera.” (The shared toaster with regular bread is one of the most common gluten contamination sources that patients do not detect. Bread crumbs accumulate on the heating elements and the bottom and are not eliminated by ordinary cleaning. For celiac disease, a dedicated toaster for gluten-free bread only is needed — marked and stored separately. The same applies to the pasta colander, wooden cutting boards, and wooden spoons.)
- Explaining condiment jar cross-contamination: “La mantequilla, la mantequilla de cacahuate, la mayonesa y la mermelada compartidas en casa son fuentes frecuentes de contaminación cuando se mete el cuchillo después de usarlo en pan regular. Esas migas van al frasco y quedan ahí. La solución es tener envases propios de esos productos marcados para su uso exclusivo, o usar cucharas limpias cada vez que saca producto del frasco.” (Shared butter, peanut butter, mayonnaise, and jam at home are frequent contamination sources when the knife is dipped after using it on regular bread. Those crumbs go into the jar and stay there. The solution is to have personal containers of those products marked for exclusive use, or to use clean spoons each time you take product from the jar.)
- Explaining that soy sauce contains gluten: “La salsa de soja regular — incluyendo Kikkoman y la mayoría de las marcas comunes — se elabora con trigo en el proceso de fermentación y contiene gluten. En recetas que usan salsa de soja, el reemplazo es el tamari, que es una salsa de soja elaborada sin trigo y está disponible en la mayoría de los supermercados. También hay que verificar el vinagre de malta — que aparece en papas fritas y aderezos — porque viene de la cebada.” (Regular soy sauce — including Kikkoman and most common brands — is made with wheat in the fermentation process and contains gluten. In recipes that use soy sauce, the replacement is tamari, which is a soy sauce made without wheat and is available in most supermarkets. Malt vinegar — which appears in chips and dressings — also needs to be checked because it comes from barley.)
- Explaining oat avenin cross-reactivity: “La avena — incluso la certificada sin gluten — contiene una proteína llamada avenina que es similar al gluten del trigo. La mayoría de las personas con celiaquía toleran la avena certificada, pero un 5 a 10 por ciento reaccionan a la avenina igual que al trigo. El etiquetado ‘sin gluten’ en la avena indica que no hay contaminación con trigo — no garantiza que la avenina propia de la avena no cause reacción. Si los síntomas no mejoran con una dieta sin gluten aparentemente estricta, probar cuatro semanas completamente sin avena puede identificar si la avenina es el problema.” (Oats — even certified gluten-free oats — contain a protein called avenin that is similar to wheat gluten. Most people with celiac disease tolerate certified oats, but 5 to 10 percent react to avenin the same way as to wheat. The ‘gluten-free’ label on oats indicates there is no wheat contamination — it does not guarantee that the oat’s own avenin will not cause a reaction. If symptoms do not improve on a seemingly strict gluten-free diet, trying four weeks completely without oats can identify whether avenin is the problem.)
- Explaining the monitoring schedule after diagnosis: “Después de empezar la dieta sin gluten, se hace un análisis de sangre para tTG-IgA a los seis meses para ver si los anticuerpos van bajando — si están bajando, la dieta está funcionando. Al año se repite la biopsia del duodeno para confirmar que las vellosidades están sanando. Si los anticuerpos siguen elevados al año o los síntomas persisten, hay que revisar la dieta para identificar fuentes de contaminación que no se han detectado. La meta a largo plazo es que el tTG-IgA vuelva a la normalidad y la biopsia muestre mucosa normal — eso significa que la dieta está funcionando completamente.” (After starting the gluten-free diet, a blood test for tTG-IgA is done at six months to see if antibodies are decreasing — if they are decreasing, the diet is working. At one year, the duodenal biopsy is repeated to confirm that the villi are healing. If antibodies remain elevated at one year or symptoms persist, the diet needs to be reviewed to identify contamination sources that have not been detected. The long-term goal is for tTG-IgA to return to normal and the biopsy to show normal mucosa — that means the diet is working completely.)
FAQs: celiac disease, Spanish-speaking patients, and celiac nursing communication
How do celiac disease clinic nurses explain to a Spanish-speaking patient’s family why a lifelong gluten-free diet is required when the patient has no stomach pain?
Celiac disease is a T-cell-mediated autoimmune enteropathy in which gliadin peptides from wheat, rye, and barley activate CD4+ T cells in the lamina propria that release interferon-gamma and activate intraepithelial lymphocytes that directly kill enterocytes, producing villous atrophy. This mucosal immune activation occurs on every encounter with gliadin, whether or not the villous atrophy produces gastrointestinal symptoms. Approximately 30 percent of patients with biopsy-confirmed Marsh III villous atrophy on a gluten-containing diet have no meaningful GI symptoms. The long-term consequences of untreated villous atrophy accrue regardless of symptom status: persistent calcium malabsorption produces osteoporosis and a 2 to 4 times elevated fracture risk; iron and folate malabsorption produce refractory anemia and elevated infertility and recurrent pregnancy loss risk; and chronic T-cell activation in the intestinal epithelium carries a 3 to 7 times elevated risk of enteropathy-associated T-cell lymphoma, an aggressive primary intestinal lymphoma arising from chronically activated intraepithelial lymphocytes. The gluten-free diet stops the mucosal immune activation, allowing the villi to heal, calcium and iron absorption to normalize, and the long-term lymphoma-driving T-cell stimulation to cease. The Spanish frame: “El intestino puede estar dañado aunque no haya síntomas. El daño autoinmune y sus complicaciones a largo plazo dependen de si llega gluten al intestino — no de si el paciente siente ese daño. La dieta sin gluten es el único tratamiento que detiene el daño y permite la curación.”
How do celiac disease clinic nurses explain to a Spanish-speaking patient why a negative tTG-IgA result does not rule out celiac disease when the patient is already on a gluten-free diet?
tTG-IgA is an IgA antibody produced by the intestinal immune system in response to ongoing gliadin-driven mucosal immune activation. When gluten is removed from the diet, gliadin peptides stop arriving at the lamina propria, the mucosal immune response diminishes, and the B cells producing tTG-IgA lose their activating stimulus. Antibody titers fall and normalize within 6 to 12 months in patients with celiac disease on a strict GFD. A negative tTG-IgA in a patient who has been on a GFD for 3 months is the expected result in a celiac patient — it does not exclude celiac disease. The diagnosis of celiac disease requires tTG-IgA testing while the patient is actively consuming at least 3 grams of gluten per day (approximately two slices of regular bread) for a minimum of 6 to 8 weeks, followed by upper endoscopy with duodenal biopsy if tTG-IgA is elevated. For patients unable or unwilling to undergo gluten challenge, HLA-DQ2/DQ8 genotyping does not change with diet; negativity for both effectively excludes celiac disease (>99% sensitivity); positivity is necessary but not sufficient and requires gluten challenge for confirmation. The Spanish frame: “La prueba de tTG-IgA solo tiene valor cuando el intestino está en contacto con gluten. Con dieta sin gluten, el resultado negativo era esperado y no descarta la celiaquía. Para el diagnóstico correcto hay que comer gluten durante seis a ocho semanas antes de la prueba, o hacer la prueba genética del HLA que no cambia con la dieta.”
How do celiac disease clinic nurses explain to a Spanish-speaking patient why a strict gluten-free diet is still causing symptoms after twelve weeks?
Persistent symptoms on a seemingly strict GFD most commonly reflect one of three hidden failure modes. First, cookware and kitchen utensil cross-contamination: porous surfaces (wooden cutting boards, wooden spoons, plastic colanders with textured grooves) and shared appliances (toasters, pasta rollers) retain gluten residue from prior use that survives ordinary washing; a shared toaster or colander can transfer enough gluten to exceed the approximately 10 mg/day threshold that studies associate with ongoing mucosal activation in sensitive celiac patients. Second, ingredient label misreading: soy sauce is brewed with wheat (tamari is the gluten-free alternative); malt vinegar and malt extract are derived from barley; shared condiment jars (butter, peanut butter, jam) are contaminated by knife-transferred wheat crumbs. Third, oat avenin cross-reactivity: avenin is a prolamin in oats structurally related to gliadin; 5 to 10 percent of celiac patients mount an intestinal immune response to avenin sufficient to maintain mucosal inflammation regardless of whether oats are certified gluten-free. A systematic kitchen and diet review identifying these three categories resolves persistent symptoms in the majority of patients with no other complicating diagnosis. The Spanish frame: “Tres fuentes ocultas que escapan a la lectura de etiquetas: el tostador y escurridor compartidos, la salsa de soja con trigo y condimentos con vinagre de malta, y la avena certificada sin gluten cuya avenina en algunos pacientes produce la misma reacción que el trigo.”
How do celiac disease clinic nurses explain the difference between celiac disease and non-celiac gluten sensitivity to Spanish-speaking patients?
Celiac disease is defined by three criteria: HLA-DQ2/DQ8 genetic susceptibility, a specific adaptive immune response (gliadin-specific CD4+ T cells, tTG-IgA antibodies), and histological intestinal mucosal damage on biopsy (Marsh I–III). The long-term complications of untreated celiac disease — lymphoma, osteoporosis, anemia, infertility — result from the T-cell-mediated mucosal damage and chronic intraepithelial lymphocyte activation. Non-celiac gluten sensitivity (NCGS) is a clinical syndrome in which GI and extra-intestinal symptoms occur with gluten ingestion but without the celiac serological markers (tTG-IgA negative with normal total IgA) and without Marsh II–III histological findings on biopsy. The mechanism is not definitively established but does not involve the same T-cell-mediated autoimmune attack on enterocytes. NCGS patients do not carry the same lymphoma, osteoporosis, or infertility risk as untreated celiac patients because the underlying mechanism — persistent mucosal T-cell activation and villous atrophy — is absent. In clinical practice, this means the stakes of occasional accidental gluten exposure differ: for a celiac patient any gluten exposure triggers the same autoimmune cascade that caused villous atrophy, making even small cross-contamination clinically meaningful; for an NCGS patient the dietary restriction may be calibrated to symptom sensitivity without the same long-term complication risk. The Spanish frame: “Celiaquía confirmada por biopsia tiene riesgo a largo plazo de linfoma, osteoporosis y anemia por el daño autoinmune continuo — por eso la dieta tiene que ser estricta de por vida. Sensibilidad al gluten no celíaca produce síntomas pero sin ese daño autoinmune confirmado, por lo que los riesgos a largo plazo no son equivalentes.”
What are the key Spanish phrases celiac disease clinic nurses use when explaining the gluten-free diet, diagnosis, and cross-contamination to Spanish-speaking patients?
Four recurring communication moments where precise language matters. When explaining why lifelong GFD is required even without symptoms: “La dieta sin gluten en la celiaquía no es para que los síntomas mejoren — es para que el sistema inmune deje de destruir las vellosidades del intestino. El daño ocurre aunque no haya síntomas. Con el tiempo ese daño silencioso causa osteoporosis, anemia crónica, y en casos raros un linfoma intestinal. Sin la dieta, el daño continúa aunque usted no lo sienta.” (The gluten-free diet in celiac disease is not so that symptoms improve — it is so that the immune system stops destroying the intestinal villi. The damage occurs even without symptoms. Over time this silent damage causes osteoporosis, chronic anemia, and in rare cases an intestinal lymphoma. Without the diet, the damage continues even if you do not feel it.) When explaining why celiac testing must be done while eating gluten: “La prueba de anticuerpos para celiaquía solo funciona si hay gluten en la dieta — sin gluten, los anticuerpos vuelven a la normalidad en semanas y la prueba sale negativa aunque la enfermedad exista. Para que el resultado sea confiable, hay que comer gluten durante al menos seis a ocho semanas antes de la prueba: el equivalente a dos rebanadas de pan al día.” (The celiac antibody test only works if there is gluten in the diet — without gluten, antibodies return to normal in weeks and the test comes back negative even if the disease exists. For the result to be reliable, gluten must be eaten for at least six to eight weeks before the test: the equivalent of two slices of bread per day.) When reviewing the top cross-contamination risks in the home kitchen: “Las tres fuentes de gluten oculto más comunes en casa son: el tostador compartido con pan regular (las migas se acumulan en las resistencias y no se eliminan con la limpieza); los envases de mantequilla, mantequilla de cacahuate o mermelada compartidos donde el cuchillo que tocó pan regular contamina el contenido; y la salsa de soja que contiene trigo — el reemplazo es el tamari. El escurridor de pasta de plástico o madera también retiene residuo de gluten después del lavado ordinario.” (The three most common hidden gluten sources at home are: the shared toaster with regular bread (crumbs accumulate on the heating elements and are not eliminated by cleaning); shared containers of butter, peanut butter, or jam where a knife that touched regular bread contaminates the contents; and soy sauce which contains wheat — the replacement is tamari. The plastic or wooden pasta colander also retains gluten residue after ordinary washing.) When explaining that persistent symptoms on a GFD may be oat avenin: “Si lleva más de dos meses con dieta sin gluten estricta y todavía tiene síntomas, una causa que mucha gente no conoce es la avenina de la avena — una proteína de la avena similar al gluten del trigo que entre el 5 y el 10 por ciento de las personas con celiaquía no toleran aunque la avena sea certificada sin gluten. Eliminar la avena completamente durante cuatro semanas — incluyendo la avena etiquetada sin gluten — y ver si los síntomas mejoran es la forma de identificar si la avenina es el problema.” (If more than two months have passed on a strict gluten-free diet and symptoms persist, a cause many people do not know is oat avenin — an oat protein similar to wheat gluten that 5 to 10 percent of people with celiac disease do not tolerate even when the oats are certified gluten-free. Eliminating oats completely for four weeks — including oats labeled gluten-free — and seeing whether symptoms improve is the way to identify whether avenin is the problem.)